These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Arginine supplementation improves rotorod performance in sickle transgenic mice. Fasipe FR; Ubawike AE; Eva R; Fabry ME Hematology; 2004 Aug; 9(4):301-5. PubMed ID: 15621739 [TBL] [Abstract][Full Text] [Related]
47. Fibrinogen deficiency, but not plasminogen deficiency, increases mortality synergistically in combination with sickle hemoglobin SAD in transgenic mice. Roszell NJ; Danton MJ; Jiang M; Witte D; Daugherty C; Grimes T; Girdler B; Anderson KP; Franco RS; Degen JL; Joiner CH Am J Hematol; 2007 Dec; 82(12):1044-8. PubMed ID: 17722076 [TBL] [Abstract][Full Text] [Related]
48. Correction of sickle cell disease by homologous recombination in embryonic stem cells. Wu LC; Sun CW; Ryan TM; Pawlik KM; Ren J; Townes TM Blood; 2006 Aug; 108(4):1183-8. PubMed ID: 16638928 [TBL] [Abstract][Full Text] [Related]
49. Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta-globin gene deletion. Andersson BA; Wering ME; Luo HY; Basran RK; Steinberg MH; Smith HP; Chui DH Eur J Haematol; 2007 Jan; 78(1):82-5. PubMed ID: 17038017 [TBL] [Abstract][Full Text] [Related]
50. Structure of fully liganded Hb ζ2β2s trapped in a tense conformation. Safo MK; Ko TP; Abdulmalik O; He Z; Wang AH; Schreiter ER; Russell JE Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2061-71. PubMed ID: 24100324 [TBL] [Abstract][Full Text] [Related]
51. Transgenic and gene knock-out mouse models of sickle cell anemia and the thalassemias. Pászty C Curr Opin Hematol; 1997 Mar; 4(2):88-93. PubMed ID: 9107524 [TBL] [Abstract][Full Text] [Related]
53. Use of restriction endonucleases for mapping the allele for beta s-globin. Wilson JT; Milner PF; Summer ME; Nallaseth FS; Fadel HE; Reindollar RH; McDonough PG; Wilson LB Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3628-31. PubMed ID: 6285354 [TBL] [Abstract][Full Text] [Related]
54. Gene replacement therapy for sickle cell disease and other blood disorders. Townes TM Hematology Am Soc Hematol Educ Program; 2008; ():193-6. PubMed ID: 19074080 [TBL] [Abstract][Full Text] [Related]
55. In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. Embury SH; Mohandas N; Paszty C; Cooper P; Cheung AT J Clin Invest; 1999 Mar; 103(6):915-20. PubMed ID: 10079113 [TBL] [Abstract][Full Text] [Related]
56. Loss of NRF2 function exacerbates the pathophysiology of sickle cell disease in a transgenic mouse model. Zhu X; Xi C; Thomas B; Pace BS Blood; 2018 Feb; 131(5):558-562. PubMed ID: 29255069 [TBL] [Abstract][Full Text] [Related]
57. A transgenic mouse model of hemoglobin S Antilles disease. Popp RA; Popp DM; Shinpock SG; Yang MY; Mural JG; Aguinaga MP; Kopsombut P; Roa PD; Turner EA; Rubin EM Blood; 1997 Jun; 89(11):4204-12. PubMed ID: 9166865 [TBL] [Abstract][Full Text] [Related]
58. The transgenic SAD mouse: a model of human sickle cell glomerulopathy. De Paepe ME; Trudel M Kidney Int; 1994 Nov; 46(5):1337-45. PubMed ID: 7853792 [TBL] [Abstract][Full Text] [Related]
59. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes. Embury SH; Clark MR; Monroy G; Mohandas N J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472 [TBL] [Abstract][Full Text] [Related]
60. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. Nagel RL; Fabry ME; Pagnier J; Zohoun I; Wajcman H; Baudin V; Labie D N Engl J Med; 1985 Apr; 312(14):880-4. PubMed ID: 2579336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]